Stolte H - Search Results

1

Urinary proteins and enzymes as early indicators of renal dysfunction in chronic exposure to cadmium.

Jung K, Pergande M, Graubaum HJ, Fels LM, Endl U, Stolte H. Jung K, et al. Among authors: stolte h. Clin Chem. 1993 May;39(5):757-65. Clin Chem. 1993. PMID: 7683580

2

[Excretion of beta-N-acetylglucosaminidase in urine of patients with kidney transplants and workers exposed to cadmium].

Jung K, Priem F, Stolte H, Graubaum HJ, May G. Jung K, et al. Among authors: stolte h. Wien Klin Wochenschr Suppl. 1991;189:56-9. Wien Klin Wochenschr Suppl. 1991. PMID: 1962486 German.

3

Changed excretion of urinary proteins and enzymes by chronic exposure to lead.

Pergande M, Jung K, Precht S, Fels LM, Herbort C, Stolte H. Pergande M, et al. Among authors: stolte h. Nephrol Dial Transplant. 1994;9(6):613-8. doi: 10.1093/ndt/9.6.613. Nephrol Dial Transplant. 1994. PMID: 7526273

4

Nephron target sites in chronic exposure to lead.

Fels LM, Herbort C, Pergande M, Jung K, Hotter G, Roselló J, Gelpi E, Mutti A, De Broe M, Stolte H. Fels LM, et al. Among authors: stolte h. Nephrol Dial Transplant. 1994;9(12):1740-6. Nephrol Dial Transplant. 1994. PMID: 7708257

5

Cisplatin nephrotoxicity and protection by silibinin.

Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Gaedeke J, et al. Among authors: stolte h. Nephrol Dial Transplant. 1996 Jan;11(1):55-62. Nephrol Dial Transplant. 1996. PMID: 8649653

6

Cathepsin B and L in isolated proximal tubular segments during acute and chronic proteinuria.

Eisenberger U, Fels LM, Olbricht CJ, Stolte H. Eisenberger U, et al. Among authors: stolte h. Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. Ren Physiol Biochem. 1995. PMID: 7539538

7

Renal fibronectin excretion as a marker for renal environmental toxins.

Bundschuh I, Herbort C, Fels LM, Jung K, Graubaum HJ, Stolte H. Bundschuh I, et al. Among authors: stolte h. Contrib Nephrol. 1993;101:177-84. doi: 10.1159/000422128. Contrib Nephrol. 1993. PMID: 8467673 No abstract available.

8

Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's disease.

Fels LM, Bokemeyer C, van Rhee J, Schmoll HJ, Stolte H. Fels LM, et al. Among authors: stolte h. Oncology. 1996 Jan-Feb;53(1):73-8. doi: 10.1159/000227539. Oncology. 1996. PMID: 8570137

9

Adverse effects of chronic low level lead exposure on kidney function--a risk group study in children.

Fels LM, Wünsch M, Baranowski J, Norska-Borówka I, Price RG, Taylor SA, Patel S, De Broe M, Elsevier MM, Lauwerys R, Roels H, Bernard A, Mutti A, Gelpi E, Roselló J, Stolte H. Fels LM, et al. Among authors: stolte h. Nephrol Dial Transplant. 1998 Sep;13(9):2248-56. doi: 10.1093/ndt/13.9.2248. Nephrol Dial Transplant. 1998. PMID: 9761504

10

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.

Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H. Bokemeyer C, et al. Among authors: stolte h. Br J Cancer. 1996 Dec;74(12):2036-41. doi: 10.1038/bjc.1996.673. Br J Cancer. 1996. PMID: 8980410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters